drug for the treatment of coronavirus infection aviewer will be free in Russia in the framework of the OMC, said Friday, June 5, the head of the Russian direct investment Fund (RDIF) Kirill Dmitriev during online meetings with President Vladimir Putin.
“the Drug on June 11 will go to the Russian clinics and will be provided free of charge for Russians, according to the program of the MLA. We also conduct drug tests for treatment on an outpatient basis and initially will produce 700 thousand units per year,” he said.
further, as noted Dmitriev, production can reach 2 million courses a year.
He also noted that the Fund has already sold more than 10 million tests to identify COVID-19 in other countries, as “it is one of the best tests.”
in addition, the head of the Russian direct investment FUND announced that the Fund will be jointly with the company “in Durban,” the holding company “System” and “R-Pharm” to invest in the production of two vaccines against coronavirus.
June 1, Deputy Director of the National research center of tuberculosis and infectious diseases of Ministry of health of the Russian Federation Vladimir closets stated that the effectiveness of avifauna during the test was about 90%.
Aviewer received a registration certificate from the Ministry of health of Russia and became the world’s first drug on the basis of Japanese favipiravir approved for the treatment of COVID-19, the report said the FUND, received on June 1 in Izvestia. Favipiravir well understood, as it was used in Japan from 2014 in the treatment of severe influenza.
According to June 5, in Russia revealed 449 834 cases COVID-19, fixed 5528 deaths, 212 680 recovered.
